EA015127B1 - Антагонисты мсн-рецепторов - Google Patents

Антагонисты мсн-рецепторов Download PDF

Info

Publication number
EA015127B1
EA015127B1 EA200870517A EA200870517A EA015127B1 EA 015127 B1 EA015127 B1 EA 015127B1 EA 200870517 A EA200870517 A EA 200870517A EA 200870517 A EA200870517 A EA 200870517A EA 015127 B1 EA015127 B1 EA 015127B1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyridin
methoxy
chlorophenyl
thieno
group
Prior art date
Application number
EA200870517A
Other languages
English (en)
Russian (ru)
Other versions
EA200870517A1 (ru
Inventor
Маклин Брайан Арнольд
Ен Дао
Кевин Мэттью Гардинир
Дэвид Джозеф Гармен
Стивен Джеймс Грин
Эрик Джеймс Хембр
Цзяньлян Лу
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200870517A1 publication Critical patent/EA200870517A1/ru
Publication of EA015127B1 publication Critical patent/EA015127B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA200870517A 2006-06-08 2007-06-08 Антагонисты мсн-рецепторов EA015127B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
PCT/US2007/070662 WO2007146758A2 (en) 2006-06-08 2007-06-08 Novel mch receptor antagonists

Publications (2)

Publication Number Publication Date
EA200870517A1 EA200870517A1 (ru) 2009-04-28
EA015127B1 true EA015127B1 (ru) 2011-06-30

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870517A EA015127B1 (ru) 2006-06-08 2007-06-08 Антагонисты мсн-рецепторов

Country Status (10)

Country Link
US (2) US8263772B2 (https=)
EP (1) EP2029609A2 (https=)
JP (1) JP5198439B2 (https=)
CN (1) CN101454328A (https=)
AU (1) AU2007257922A1 (https=)
BR (1) BRPI0712680A2 (https=)
CA (1) CA2652385A1 (https=)
EA (1) EA015127B1 (https=)
MX (1) MX2008015662A (https=)
WO (1) WO2007146758A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2700411C2 (ru) * 2015-03-09 2019-09-17 Астеллас Фарма Инк. ПРОИЗВОДНЫЕ ФУРО[3,2-c]ПИРИДИНА ИЛИ ТИЕНО[3,2-c]ПИРИДИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ НИКТУРИИ

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2740193A1 (en) 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
EP2367823A1 (en) 2008-12-23 2011-09-28 Abbott Laboratories Anti-viral compounds
BRPI0923527A2 (pt) * 2008-12-24 2016-08-09 Syngenta Ltd métodos de preparo de fungicidas
CN102459165B (zh) * 2009-04-15 2015-09-02 Abbvie公司 抗病毒化合物
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
UA118080C2 (uk) 2009-06-11 2018-11-26 Еббві Айрленд Анлімітед Компані Противірусні сполуки
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US20150065343A1 (en) 2012-04-02 2015-03-05 Basf Se Acrylamide compounds for combating invertebrate pests
BR112014027133A2 (pt) 2012-05-09 2017-06-27 Basf Se compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
MX394360B (es) 2013-03-14 2025-03-24 Sumitomo Pharma Oncology Inc Inhibidores de jak2 y alk2 y metodos para su uso.
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms
ES2849951T3 (es) 2015-06-18 2021-08-24 89Bio Ltd Derivados de piperidina 4-bencil y 4-benzoil sustituidos
EA201890086A1 (ru) 2015-06-18 2018-06-29 Сефалон, Инк. 1,4-замещенные производные пиперидина
MX2021000977A (es) 2018-07-26 2021-04-12 Sumitomo Pharma Oncology Inc Metodos para tratar enfermedades asociadas con expresion anormal de receptor de activina a tipo 1 (acvr1) e inhibidores de acvr1 para uso en los mismos.
CN113226322A (zh) 2018-10-30 2021-08-06 诺维逊生物股份有限公司 作为bet抑制剂的杂环化合物
EP3997070A4 (en) 2019-07-02 2023-07-26 Nuvation Bio Inc. HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
US20260028336A1 (en) * 2022-07-20 2026-01-29 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033476A1 (en) * 2001-10-15 2003-04-24 Smithkline Beecham Plc Pyrimidinones as melanin concentrating hormone receptor 1
WO2005047293A1 (en) * 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
WO2007093364A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
US20070078125A1 (en) * 2003-10-23 2007-04-05 Glaxo Group Limited Arylamine mch r1 antagonists
UA83416C2 (en) * 2004-02-13 2008-07-10 Баниу Фармасьютикал Ко., Лтд. Fused ring 4-oxopyrimidine derivative
US20050256124A1 (en) * 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
MXPA06014535A (es) 2004-06-18 2007-06-05 Biolipox Ab Indoles utiles en el tratamiento de la inflamacion.
US7902356B2 (en) * 2004-12-17 2011-03-08 Eli Lilly And Company Thiazolopyridinone derivates as MCH receptor antagonists
KR20080094699A (ko) * 2006-02-15 2008-10-23 사노피-아벤티스 신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033476A1 (en) * 2001-10-15 2003-04-24 Smithkline Beecham Plc Pyrimidinones as melanin concentrating hormone receptor 1
WO2005047293A1 (en) * 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
WO2007093364A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DYCK V. ET AL.: "A Thienopyridazinone-Based Melanin-Concentrating Hormone Receptor 1 Antagonist with Potent in Vivo Anorectic Properties". JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 49, no. 13, 28 May 2006 (2006-05-28), pages 3753-3756, XP003003117, ISSN: 0022-2623, cited in the application, compounds 21A-21F *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2700411C2 (ru) * 2015-03-09 2019-09-17 Астеллас Фарма Инк. ПРОИЗВОДНЫЕ ФУРО[3,2-c]ПИРИДИНА ИЛИ ТИЕНО[3,2-c]ПИРИДИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ НИКТУРИИ

Also Published As

Publication number Publication date
US20090093456A1 (en) 2009-04-09
JP5198439B2 (ja) 2013-05-15
BRPI0712680A2 (pt) 2012-11-20
EP2029609A2 (en) 2009-03-04
WO2007146758A3 (en) 2008-02-07
EA200870517A1 (ru) 2009-04-28
WO2007146758A2 (en) 2007-12-21
CA2652385A1 (en) 2007-12-21
US8263772B2 (en) 2012-09-11
JP2009539875A (ja) 2009-11-19
AU2007257922A1 (en) 2007-12-21
MX2008015662A (es) 2009-01-12
CN101454328A (zh) 2009-06-10
US20120302547A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
EA015127B1 (ru) Антагонисты мсн-рецепторов
AU2019246753B2 (en) Novel compounds and compositions for inhibition of FASN
ES2881508T3 (es) Derivados de 6,7-dihidro-5H-benzo[7]anuleno como moduladores de los receptores estrogénicos
ES2389907T3 (es) Compuesto de amida heterocíclica y uso del mismo como un inhibidor de MMP-13
JP6990657B2 (ja) Ddr1阻害剤としてのスピロインドリノン
CN102264707B (zh) 双环型杂环化合物
RS54236B1 (sr) Amido jedinjenja i njihova upotreba kao farmaceutskih proizvoda
ES2687475T3 (es) Nuevos derivados de indol y de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
EP1442025A1 (en) Pyrimidinones as melanin concentrating hormone receptor 1
KR20070110329A (ko) 글라이신 트랜스포터 1의 저해제로서의 헤테로환상 치환된페닐 메탄온
WO2025011480A1 (zh) 化合物及其作为抗癌药的用途
EA015559B1 (ru) ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5H-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH
TW202229268A (zh) Cdk2抑制劑及其製備方法
US20110230470A1 (en) Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors
JP2025537254A (ja) グルカゴン様ペプチド1受容体アゴニスト
EP2501233B1 (en) Quinazoline compounds
NZ549386A (en) (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
JP5225269B2 (ja) 新規なmch受容体アンタゴニスト
JP2025526986A (ja) 新規な置換ベンゾチオフェン-6-カルボン酸誘導体、その調製方法、及びその治療的使用
JP2026514055A (ja) Erbb2阻害薬
AU2002335004A1 (en) Pyrimidinones as melanin concentrating hormone receptor 1

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU